Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives

Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives

US Patent 6169068 · Granted Jan 2, 2001

Estimated economic value: $10,476,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of forming bone with porous βtricalcium phosphate granules2008
Method of delivering a bioactive agent with porous β-tricalcium phosphate granul2008
Porous β-tricalcium phosphate granules for regeneration of bone tissue2005
Compositions comprising complement receptor type 1 molecules having carbohydrate2001
Compositions comprising complement related proteins and carbohydrates, and metho1999
Compositions comprising complement related proteins and carbohydrates, and metho1999
CEA-binding protein and uses thereof1994
Binding protein for CEA and uses thereof1994
Method for isolating CEA-binding protein1993
Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their 1993
Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their 1993
Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their 1990